CDSCO directs drug regulators to strictly monitor end-use of dual-use APIs

New Delhi: Through a recent Office Memorandum, Central Drugs Standard Control Organisation (CDSCO) has directed drug regulators to strictly monitor the end-use of dual-use Active Pharmaceutical Ingredients and apprise the apex drug regulator about the action taken in the matter.

Dual-use APIs are the ones that can be used in making special food products such as nutraceuticals apart from medicines.

Accordingly, the matter was examined and it has been decided;

"If the manufacturer himself is importing such products for their end use (other than medicinal use), one time dual use NOC may be granted for one year to such manufacturers under the intimation to this office based on the assessment of at least one year data and written undertaking by the manufacturer justifying the quantity proposed for one year."

CDSCO further added;

The period of one year may be further relaxed if the data submitted and the operations carried out by the operators indicate to prove that it is for self-consumption for further manufacturing

However, the nodal authority once again directed the drug officers to strictly monitor the end-use of dual-use Active Pharmaceutical Ingredients and action taken in this matter to be communicated to the apex drug regulator.

Also Read: CDSCO apprises about the Continuity in a validity of Written Confirmation Certificate for API consignments for Exports